Evolution of SARS CoV-2 Omicron subvariants BF.7 and XBB.1.5: Time to follow Africa and abort all COVID restrictions

被引：10
|
作者：
Kelleni, Mina T. [1 ]
机构：
[1] Minia Univ, Coll Med, Pharmacol Dept, Al Minya, Egypt
来源：
JOURNAL OF INFECTION | 2023年 / 86卷 / 04期
关键词：
D O I：
10.1016/j.jinf.2023.01.027
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：405 / 405
页数：1
相关论文
共 29 条
  • [1] Possible threat of the Omicron subvariants XBB.1.5 and BF.7 to the Indian subcontinent: A correspondence
    Ghosh, Shankhaneel
    Shree, Anagha
    NEW MICROBES AND NEW INFECTIONS, 2023, 52
  • [2] Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2
    Zhu, Airu
    Wei, Peilan
    Man, Miao
    Liu, Xuesong
    Ji, Tianxing
    Chen, Jiantao
    Chen, Canjie
    Huo, Jiandong
    Wang, Yanqun
    Zhao, Jincun
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [3] Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2
    Airu Zhu
    Peilan Wei
    Miao Man
    Xuesong Liu
    Tianxing Ji
    Jiantao Chen
    Canjie Chen
    Jiandong Huo
    Yanqun Wang
    Jincun Zhao
    Signal Transduction and Targeted Therapy, 8
  • [4] The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
    Ao, Danyi
    He, Xuemei
    Hong, Weiqi
    Wei, Xiawei
    MEDCOMM, 2023, 4 (02):
  • [5] COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2
    Chen, Wei-Chun
    Hu, Shu-Yu
    Shen, Ching-Fen
    Chuang, Hui-Yu
    Ker, Chin-Ru
    Shen, Ching-Ju
    Cheng, Chao-Min
    VACCINES, 2023, 11 (09)
  • [6] Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals
    Kosugi, Yusuke
    Kaku, Yu
    Hinay, Alfredo A., Jr.
    Guo, Ziyi
    Uriu, Keiya
    Kihara, Minoru
    Saito, Fumitake
    Uwamino, Yoshifumi
    Kuramochi, Jin
    Shirakawa, Kotaro
    Takaori-Kondo, Akifumi
    Sato, Kei
    LANCET INFECTIOUS DISEASES, 2024, 24 (03): : e147 - e148
  • [7] Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?
    Varghese, Ryan
    Kumar, Dileep
    Sharma, Rohit
    HUMAN CELL, 2023, 36 (03) : 1218 - 1221
  • [8] Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?
    Ryan Varghese
    Dileep Kumar
    Rohit Sharma
    Human Cell, 2023, 36 : 1218 - 1221
  • [9] New SARS-CoV-2 Omicron subvariant. Is XBB.1.5 associated with an increase in COVID-19 morbidity?
    Jaskola-Polkowska, Dominika Maria
    Chcialowski, Andrzej Wiktor
    Kruszewski, Jerzy Andrzej
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2023, 19 (03): : 169 - 174
  • [10] A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
    Thimmiraju, Syamala Rani
    Adhikari, Rakesh
    Villar, Maria Jose
    Lee, Jungsoon
    Liu, Zhuyun
    Kundu, Rakhi
    Chen, Yi-Lin
    Sharma, Suman
    Ghei, Karm
    Keegan, Brian
    Versteeg, Leroy
    Gillespie, Portia M.
    Ciciriello, Allan
    Islam, Nelufa Y.
    Poveda, Cristina
    Uzcategui, Nestor
    Chen, Wen-Hsiang
    Kimata, Jason T.
    Zhan, Bin
    Strych, Ulrich
    Bottazzi, Maria Elena
    Hotez, Peter J.
    Pollet, Jeroen
    VACCINES, 2023, 11 (10)
123